1. Home
  2. EW vs PSX Comparison

EW vs PSX Comparison

Compare EW & PSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

HOLD

Current Price

$86.99

Market Cap

45.5B

Sector

Health Care

ML Signal

HOLD

Logo Phillips 66

PSX

Phillips 66

HOLD

Current Price

$128.65

Market Cap

52.0B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
EW
PSX
Founded
1958
1875
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Integrated oil Companies
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
45.5B
52.0B
IPO Year
2000
2012

Fundamental Metrics

Financial Performance
Metric
EW
PSX
Price
$86.99
$128.65
Analyst Decision
Buy
Buy
Analyst Count
20
20
Target Price
$95.83
$144.68
AVG Volume (30 Days)
3.0M
2.4M
Earning Date
02-10-2026
02-04-2026
Dividend Yield
N/A
3.76%
EPS Growth
N/A
N/A
EPS
2.33
3.66
Revenue
$5,883,800,000.00
$131,953,000,000.00
Revenue This Year
$14.29
N/A
Revenue Next Year
$9.68
N/A
P/E Ratio
$37.28
$34.94
Revenue Growth
10.60
N/A
52 Week Low
$65.94
$91.01
52 Week High
$87.89
$144.96

Technical Indicators

Market Signals
Indicator
EW
PSX
Relative Strength Index (RSI) 60.64 37.24
Support Level $85.79 $127.94
Resistance Level $86.98 $130.06
Average True Range (ATR) 1.47 3.18
MACD 0.12 -1.08
Stochastic Oscillator 90.52 8.93

Price Performance

Historical Comparison
EW
PSX

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

About PSX Phillips 66

Phillips 66 is an independent refiner that owns or holds interest in 10 refineries with a total crude throughput capacity of 1.9 million barrels per day, or mmb/d, at the end of 2025. The midstream segment comprises extensive transportation and NGL processing assets. It includes 70,000 miles of crude oil, refined petroleum product, NGL and natural gas pipeline systems, and a comprehensive set of refined petroleum product, NGL and crude oil terminals, gathering and processing plants and fractionation facilities and various other storage and loading facilities. Its CPChem chemical joint venture operates facilities primarily in the United States and the Middle East and produces olefins and polyolefins.

Share on Social Networks: